Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population

Completed · Phase 4

Conditions studied: Actinic Keratosis

In brief

The purpose of this research study is to measure adherence to the study drug (Carac) for the treatment of actinic keratoses.

Key facts

Study ID

NCT00696488

Run by

Wake Forest University

People needed

20

Starts

2007-04-01

Expected to finish

2008-10-01

Last updated by the study team

2018-09-10

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any male or female 50 years of age or older with moderate to severe actinic keratoses of the face and anterior scalp diagnosed by a dermatologist will be eligible for participation.

You may not qualify if…

• Age less than 50.
• Known allergy or sensitivity to topical Carac® in the subject.
• Inability to complete all study-related visits.
• Introduction of any other prescription medication, topical or systemic, for actinic keratosis while participating in the study.
• Subjects should not receive surgical or cryotherapy while participating in the study.
• Pregnant women, women who are breast feeding, or women of child bearing potential who are not practicing two acceptable methods of birth control

Where it is running

• Wake Forest University Health Sciences Dermatology — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.